Home > Clinical Trials

Saved trials

Completed
NCT01565668
Open Label Study to Evaluate Safety and Efficacy of 2 Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
76 Enrollment(s)
24 Study location(s)
Interventional (Phase II)
Leukemia, Myeloid, Acute
Completed
NCT02952599
Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Korea and Taiwan (ETNA-VTE-KOR-TWN)
352 Enrollment(s)
19 Study location(s)
Observational
Venous Thromboembolism
Completed
NCT04185857
MRA and ARB Treatment in Screening of Primary Aldosteronism
50 Enrollment(s)
1 Study location(s)
Observational
Primary Aldosteronism Due to Aldosterone Producing Adenoma
Unknown status
NCT04138888
A Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil/ Hydrochlorothiazide After a Single Oral Dose Administration Under Fasting Conditions
32 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
Bioequivalence
Unknown status
NCT04161001
Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451
237 Enrollment(s)
1 Study location(s)
Interventional (Phase III)
Hypertension, Dyslipidemia
Completed
NCT02581280
Population Pharmacokinetics of Teicoplanin, Levofloxacin, Piperacillin/Tazobactam, Meropenem, Vancomycin, Remifentanil, Cefepime, Cefpirome, Sufentanil, Midazolam, Clopidogrel, Ticagrelor, Prasugrel During Veno-arterial Extracorporeal Membrane Oxygenation (VA ECMO)
56 Enrollment(s)
1 Study location(s)
Observational
Cardiac Dysfunction
Unknown status
NCT04146168
Lake Washington Vascular VenaSeal™ Post-Market Evaluation
124 Enrollment(s)
3 Study location(s)
Observational
Varicose Veins
Venous Reflux
Completed
NCT01560780
Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis
84 Enrollment(s)
4 Study location(s)
Interventional (Phase III)
Coronary Artery Bypass